Kappa opioid receptor influences naltrexone's effects on drinking alcohol
Researchers at Yale University have identified how naltrexone, a medication used to treat alcohol use disorder, reduces craving and consumption in heavy drinkers. The findings appear in Biological Psychiatry published by ...
Aug 6, 2019
0
0